HHS Begs Novel Approach To Genetic Tests Pending FDA Authority Verdict
This article was originally published in The Gray Sheet
Executive Summary
The HHS Secretary's Advisory Committee on Genetic Testing is planning on a final legal review decision from FDA on oversight and premarket review of genetic tests in time for its August meeting
You may also be interested in...
HHS Genetics Panel Replaces SACGT; Thompson Defends Membership Rules
HHS' reconfigured panel on genetics policy places less focus on genetic test regulation than its predecessor, the Secretary's Advisory Committee on Genetic Testing
HHS Genetics Panel Replaces SACGT; Thompson Defends Membership Rules
HHS' reconfigured panel on genetics policy places less focus on genetic test regulation than its predecessor, the Secretary's Advisory Committee on Genetic Testing
Genetic Test Plan Under FDA Legal Review Leaves HHS Panel Wanting More
FDA's nascent program for regulating genetic tests is pending review within the Office of the Commissioner